FLT4 and neoplasm: In the present study, cancer cells were treated with human bone marrow MSC-conditioned medium (hBM-MSC-CM) for a period of time to allow the tumor cells to express the lymphatic vessel-associated markers Prox-1 and VEGFR-3.